Akèy › Skleroz an milti pwogresif kwonik › Florid
Etid klinik pou Skleroz an milti pwogresif kwonik nan Florid
4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Florid.
Vil nan Florid
Tèks ofisyèl etid la (Anglè)
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Associates, PA, Maitland
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07609719A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- SFM Clinical Research, LLC, Boca Raton
- Nova Clinical Research, LLC, Bradenton
- MS and Neuromuscular Center of Excellence, Clearwater
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Nova Clinical Research, LLC, Bradenton
- Neurology Associates, PA, Maitland
- University of South Florida Department of Neurology - MS Division, Tampa
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 22, 2026 · NCT07067463A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology of Central FL Res Ctr, Altamonte Springs
- UF Health Cancer Center, Gainesville
- Homestead Assoc In Research Inc, Homestead
- ak 8 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.